Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
International Society for Gastrointestinal Hereditary Tumours |
RCV000074760 | SCV000107970 | no known pathogenicity | Lynch syndrome | 2013-09-05 | reviewed by expert panel | research | MAF >1% |
Color Diagnostics, |
RCV000584553 | SCV000690272 | benign | Hereditary cancer-predisposing syndrome | 2017-07-12 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000202025 | SCV001158692 | benign | not specified | 2018-07-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001353436 | SCV001863113 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003315587 | SCV004015974 | benign | Lynch syndrome 5 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000202025 | SCV004233648 | benign | not specified | 2024-01-24 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 31% of patients studied by a panel of primary immunodeficiencies. Number of patients: 29. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV001353436 | SCV005243546 | benign | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV000202025 | SCV000257224 | benign | not specified | no assertion criteria provided | clinical testing | ||
Department of Pathology and Laboratory Medicine, |
RCV001353436 | SCV000592565 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics Laboratory, |
RCV000202025 | SCV001906305 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000202025 | SCV001967743 | benign | not specified | no assertion criteria provided | clinical testing |